ArticleFrontiers in microbiology2022
Occurrence of
Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 23 citations in OpenAlex.
- Review
- Prevalence and molecular characteristics of colistin-resistant Escherichia coli in livestock and fresh meat detected by a selective enrichment method.Veterinary research communications · 2026Article
- Virulence Traits and Drug Resistance of STEC Isolated from Layer Poultry andMicroorganisms · 2026Article
- mcr gene family evolution and structural mechanisms of colistin resistance: from mcr-1 to emerging variants.Archives of microbiology · 2026Review
- Colistin Resistance in Gram-Negative Bacteria: Mechanisms, Transmission, and Novel Intervention Strategies.Microorganisms · 2026Review
- Antimicrobial susceptibility and virulence traits ofFrontiers in microbiology · 2026Article
- Epidemiological trends of antibiotic resistance in pathogenic Escherichia coli in swine farms from the Northwest Iberian Peninsula and evaluation of air sampling for antibiotic resistance surveillance.Porcine health management · 2025Article
- One Health at Risk: Plasmid-Mediated Spread ofAntibiotics (Basel, Switzerland) · 2025Review
- Identification ofInternational journal of microbiology · 2025Article
- Detection and risk factor analysis of avian colibacillosis associated with colistin-resistantFrontiers in veterinary science · 2025Article
- Prevalence, characteristics, and plasmid dynamics ofFrontiers in microbiology · 2025Article
- Detection and Characterisation of Colistin-ResistantMicroorganisms · 2024Article
- First detection of multidrug-resistant and toxigenic Pasteurella aerogenes in sow vaginal discharge: a novel threat to swine health in Thailand.Scientific reports · 2024Article
- Investigation ofOne health (Amsterdam, Netherlands) · 2024Article
- High Genetic Diversity in Third-Generation Cephalosporin-ResistantPathogens (Basel, Switzerland) · 2024Article
- First report of mobile colistin resistance geneVeterinary world · 2023Article
- Farm to table: colistin resistance hitchhiking through food.Archives of microbiology · 2023Review
- Genomic traits of multidrug resistant enterotoxigenicFrontiers in microbiology · 2023Article
- Repurposing anti-inflammatory drugs for fighting planktonic and biofilm growth. New carbazole derivatives based on the NSAID carprofen: synthesis,Frontiers in cellular and infection microbiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The global emergence of plasmid-mediated colistin resistance is threatening the efficacy of colistin as one of the last treatment options against multi-drug resistant Gram-negative bacteria. To date, ten Methods and results: We determined the occurrence of Discussion: This is the first report of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.